In this video interview, David Morton, PhD, director of biostatistics at Certara, discusses how growing FDA support is ...
The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
Clinical Trials Arena on MSN
The Bayesian challenge: complexity that pays off
The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
Saria is director of the Johns Hopkins Machine Learning and Healthcare Lab. Bayesian's technology, which received an FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results